Trends in Costs for HIV Care During a Hepatitis C Virus Early Treatment and Elimination Program: A Data Linkage Study of Claims and Swiss HIV Cohort Study Data.
Increases in mean total costs for PWH in Switzerland from 2012 to 2017 were small. The contribution of DAAs for the treatment of chronic HCV to overall costs was marginal.
Authors
- Enos Bernasconi (ORCID: https://orcid.org/0000-0002-9724-8373)
- Niklaus Daniel Labhardt (ORCID: https://orcid.org/0000-0003-3599-1791)
- Matthias L. Cavassini (ORCID: https://orcid.org/0000-0003-0933-7833)
- Heiner C. Bucher (ORCID: https://orcid.org/0000-0002-0131-7873)
- Soheila Aghlmandi (ORCID: https://orcid.org/0000-0003-0180-3246)
- Kurt Schmidlin (ORCID: https://orcid.org/0000-0003-0486-4490)
- Pascal Godet (ORCID: https://orcid.org/0009-0004-0370-2603)
- Cornelia Staehelin (ORCID: https://orcid.org/0000-0002-1733-7051)
- Marcel Stoeckle (ORCID: https://orcid.org/0000-0002-0088-5078)
- Alexandra Calmy
- Huldrych F. Günthard (ORCID: https://orcid.org/0000-0002-1142-6723)
- Katharina Kusejko (ORCID: https://orcid.org/0000-0002-4638-1940)
- Carola A. Huber (ORCID: https://orcid.org/0000-0002-2469-0435)
- Patrick Schmid (ORCID: https://orcid.org/0000-0003-1978-5082)
Institutions
- University of Geneva (CH)
- University of Basel (CH)
- University of Zurich (CH)
- University of St.Gallen (CH)
- University Hospital of Basel (CH)
- Ente Ospedaliero Cantonale (CH)
- University Hospital of Zurich (CH)
- University Hospital of Geneva (CH)
Publication Details
- Journal
- PubMed
- Published
- 2025-08-01
- DOI
- https://doi.org/10.1093/ofid/ofaf410
- Primary Topic
- Hepatitis C virus research
- Type
- article
- Field-Weighted Citation Impact
- 0.00